.png){kind=icon}
.png){kind=icon}
Return
Epitope-Specific IgE Profiles are Predictive of Desensitization and Remission in the IMPACT Trial
.png){kind=icon}
PRE
AI
J
S
K
S
M
M
L
C
M
H
DOI：10.1016/j.jaci.2026.07.008.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Results from the IMPACT trial suggest that initiation of peanut oral immunotherapy (pnOIT) before age 4 years can increase chances of achieving desensitization and remission.
Journal
IF:
11.2
Papers:
3.7W
Citations:
5.6W
Organization
Cited Papers